Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2019-04-26
4:45 pm
Sale
13DOncoMed Pharmaceuticals Inc
OMED
BIOTECHNOLOGY VALUE FUND L P0
0%
-4,042,989decrease
(Position Closed)
View
2019-03-15
4:40 pm
Unchanged
13DOncoMed Pharmaceuticals Inc
OMED
BIOTECHNOLOGY VALUE FUND L P4,042,989
10.4%
0
(Unchanged)
View
2019-02-14
4:45 pm
Sale
13GOncoMed Pharmaceuticals Inc
OMED
PERCEPTIVE ADVISORS LLC1,719,111
4.5%
-901,786decrease
(-34.41%)
View
2019-02-14
4:43 pm
Sale
13GOncoMed Pharmaceuticals Inc
OMED
BIOTECHNOLOGY VALUE FUND L P4,042,989
10.5%
-228,300decrease
(-5.34%)
View
2019-02-14
06:58 am
Sale
13GOncoMed Pharmaceuticals Inc
OMED
HarbourVest Partners LLC1,901,106
4.92%
-39,992decrease
(-2.06%)
View
2019-02-13
11:23 am
Sale
13GOncoMed Pharmaceuticals Inc
OMED
Phase4 Partners Ltd0
0%
-1,943,509decrease
(Position Closed)
View
2019-02-12
12:39 pm
Purchase
13GOncoMed Pharmaceuticals Inc
OMED
DELPHI VENTURES VIII LP2,070,542
5.4%
15,000increase
(+0.73%)
View
2019-02-08
3:56 pm
Sale
13GOncoMed Pharmaceuticals Inc
OMED
PRIMECAP MANAGEMENT CO5,506,300
14.25%
-59,300decrease
(-1.07%)
View
2018-12-21
07:00 am
Purchase
13GOncoMed Pharmaceuticals Inc
OMED
HarbourVest Partners LLC1,941,098
5.02%
1,941,098increase
(New Position)
View
2018-12-17
4:16 pm
Purchase
13DOncoMed Pharmaceuticals Inc
OMED
Mereo Biopharma Group plc4,130,907
10.7%
4,130,907increase
(New Position)
View